Billing and Coding: MolDX: BluePrint® Test

BluePrint® molecular subtyping assay is statutorily excluded from Medicare coverage because evidence of clinical utility is insufficient; it is not a covered benefit. Claims should use CPT 81479, indicate the exclusion with modifier GY (use GX only if a voluntary ABN is issued), include the appropriate Z-code in the specified claim loops or paper form locators, and submit only one test identifier per paper claim.

"BluePrint® molecular subtyping assay is statutorily excluded from Medicare coverage due to insufficient evidence of clinical utility and is not a covered benefit."

Sign up to see full coverage criteria, indications, and limitations.